Back
Revvity Inc (RVTY)
Life Sciences Tools & ServicesRVTY · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$123.00
−1.40%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$2.07
ROE
3.2%
Gross margin
54.3%
Debt/Equity
0.47x
Revenue growth
7.0%
Revvity Inc — company intelligence
Earnings surprises
Q2 2026$1.41 vs $1.25 est+13.1%
Q1 2026$1.06 vs $1.04 est+2.3%
Q4 2025$1.70 vs $1.58 est+7.4%
Q3 2025$1.18 vs $1.16 est+1.7%
Analyst consensus · 25 analysts
13 Buy12 Hold0 Sell
Updated Aug 24, 2026
Insider activity · 90 days
0 buys1 sellnet -85 shares
Gonzales AnitaSell 85 · Jul 20, 2026
Recent SEC filings
4 — Insider transaction reportAug 18, 2026
4 — Insider transaction reportAug 17, 2026
10-Q — Quarterly reportAug 11, 2026
Latest news
The Top 5 Analyst Questions From Revvity’s Q2 Earnings Call — Yahoo · 1w ago
Revvity (RVTY) Q2 2026 Earnings Call Transcript — Yahoo · 2w ago
Revvity to Present at Upcoming Investor Conferences — Yahoo · 2w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.